FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and represents a recovered polynucleotide molecule with rEVE function, a recombinant expression vector, an expression shuttle vector, a host cell, as well as methods using the above recovered polynucleotide molecule. The given polynucleotide molecule with rEVE function may be used for preparing recombinant proteins. The given polynucleotide molecule with rEVE function contains a recombinant expression vector element (rEVE) containing a sequence of nucleotide bases specified in a group consisting of the nucleotide base sequence SEQ ID NO:1, the nucleotide base sequence SEQ ID NO:2, an up-regulation fragment of the sequence SEQ ID NO:1, the up-regulation fragment of the sequence SEQ ID NO:2, of the sequence complementary to any sequence as specified above, or combination thereof.
EFFECT: presented invention enables enhancing the expression of one or more proteins.
34 cl, 10 dwg, 17 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RECOMBINANT POLYPEPTIDE PRODUCTION | 2012 |
|
RU2628310C2 |
IMPROVED TRANSGENE EXPRESSION AND PROCESSING | 2014 |
|
RU2808756C1 |
NOVEL EUKARYOTIC CELLS AND METHODS FOR PREPARING THEREOF FOR RECOMBINANT EXPRESSION OF PRODUCT OF INTEREST | 2014 |
|
RU2712507C2 |
NEW VERTEBRATE CELLS AND METHODS OF RECOMBINANT EXPRESSION OF POLYPEPTIDE OF INTEREST | 2015 |
|
RU2710726C2 |
IMPROVED EXPRESSION VECTORS OF MAMMALS AND THEIR USE | 2009 |
|
RU2502800C2 |
METHOD OF PRODUCING CELL CAPABLE TO PRODUCE HETEROPROTEINS WITH HIGH YIELD | 2008 |
|
RU2486245C2 |
GENE SET EXPRESSION INCLUDING sORF CONSTRUCTS AND METHODS FOR IMMUNOGLOBULIN EXPRESSION | 2006 |
|
RU2478709C2 |
RECOMBINANT ANTIBODY IL4 USED FOR TREATMENT OF DISORDERS ASSOCIATED WITH FUNCTION OF IL4 | 1994 |
|
RU2162711C2 |
METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION | 2015 |
|
RU2704830C2 |
EXPRESSION METHOD | 2014 |
|
RU2731717C2 |
Authors
Dates
2014-06-10—Published
2008-03-28—Filed